苏盐井神(603299) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,388,280,493.01, representing a decrease of 10.10% compared to the same period last year[5]. - Net profit attributable to shareholders of the listed company was CNY 226,846,968.38, an increase of 10.23% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 214,496,990.94, up by 11.39% compared to the previous year[5]. - Basic earnings per share were CNY 0.2946, reflecting an increase of 11.97% compared to the same period last year[5]. - Diluted earnings per share were CNY 0.2937, which is an increase of 12.06% year-on-year[5]. - Total operating revenue for Q1 2024 was CNY 1,388,280,493.01, a decrease of 10.1% compared to CNY 1,544,319,898.19 in Q1 2023[22]. - Net profit for Q1 2024 reached CNY 228,852,997.65, an increase of 9.7% from CNY 208,674,188.29 in Q1 2023[23]. - Basic earnings per share for Q1 2024 were CNY 0.2946, compared to CNY 0.2631 in Q1 2023, representing a growth of 11.5%[24]. Cash Flow and Assets - The net cash flow from operating activities reached CNY 432,997,978.92, showing a significant increase of 42.63% year-on-year[5]. - The company's cash flow from operating activities showed a positive trend, contributing to the overall financial stability[25]. - In Q1 2024, the net cash flow from operating activities increased to approximately $433 million, up from $304 million in Q1 2023, representing a growth of 42.6%[27]. - Total cash inflow from operating activities was approximately $1.626 billion in Q1 2024, slightly up from $1.603 billion in Q1 2023, indicating a growth of 1.5%[26]. - Cash outflow for purchasing goods and services decreased to approximately $780 million in Q1 2024 from $887 million in Q1 2023, a reduction of 12.0%[26]. - The net cash flow from investing activities was approximately $252 million in Q1 2024, significantly up from $12.6 million in Q1 2023, marking a substantial increase[27]. - Cash inflow from financing activities totaled approximately $456 million in Q1 2024, compared to $380 million in Q1 2023, reflecting a growth of 20.0%[27]. - The ending cash and cash equivalents balance reached approximately $3.968 billion in Q1 2024, up from $2.720 billion in Q1 2023, an increase of 46.0%[27]. Assets and Liabilities - Total assets at the end of the reporting period amounted to CNY 10,715,978,442.21, representing a growth of 6.03% from the end of the previous year[6]. - Total liabilities for Q1 2024 were CNY 4,526,650,458.13, up from CNY 4,177,878,715.55 in Q1 2023, indicating a rise of 8.3%[19]. - Shareholders' equity attributable to the listed company was CNY 5,791,835,750.40, an increase of 4.38% compared to the end of the previous year[6]. - As of March 31, 2024, the company's total current assets reached approximately RMB 5.52 billion, an increase from RMB 4.93 billion as of December 31, 2023, representing a growth of about 11.87%[17]. - Cash and cash equivalents amounted to RMB 4.05 billion, up from RMB 3.10 billion, indicating a significant increase of approximately 30.54%[17]. - Accounts receivable rose to RMB 327.10 million from RMB 167.70 million, reflecting an increase of approximately 95.42%[17]. - The company's inventory stood at RMB 519.16 million, slightly down from RMB 542.10 million, showing a decrease of about 4.23%[17]. Non-Recurring Items and Other Activities - Non-recurring gains and losses totaled CNY 12,349,977.44 after tax and minority interest adjustments[9]. - The report indicates no significant changes in shareholder structure or major shareholder activities during the reporting period[15]. - The company has not disclosed any new product launches or technological advancements in this quarter[16]. - There are no significant mergers or acquisitions reported in the current quarter[16]. - The company has not provided specific future guidance or outlook for the upcoming quarters[16]. - The company reported a significant increase in accounts payable, which rose to CNY 920,229,424.52 from CNY 1,080,015,577.93 in the previous year, indicating a shift in operational financing strategies[19]. - Research and development expenses for Q1 2024 were CNY 37,572,421.75, slightly down from CNY 40,604,953.64 in Q1 2023[22]. - The company plans to expand its market presence and invest in new technologies to drive future growth[25].